Form 8-K - Current report:
SEC Accession No. 0001193125-24-162056
Filing Date
2024-06-17
Accepted
2024-06-17 08:03:33
Documents
13
Period of Report
2024-06-17
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d853346d8k.htm   iXBRL 8-K 26263
  Complete submission text file 0001193125-24-162056.txt   152248

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mirm-20240617.xsd EX-101.SCH 2850
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mirm-20240617_lab.xml EX-101.LAB 18757
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mirm-20240617_pre.xml EX-101.PRE 11710
16 EXTRACTED XBRL INSTANCE DOCUMENT d853346d8k_htm.xml XML 3782
Mailing Address 989 EAST HILLSDALE BOULEVARD, SUITE 300 FOSTER CITY CA 94404
Business Address 989 EAST HILLSDALE BOULEVARD, SUITE 300 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

EIN.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38981 | Film No.: 241046995
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)